OSUR logo

OraSure Technologies Inc. (OSUR)

$3.60

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on OSUR

Market cap

$248570158

EPS

-0.7

P/E ratio

--

Price to sales

2.39

Dividend yield

--

Beta

1.075365

Price on OSUR

Previous close

$3.62

Today's open

$3.57

Day's range

$3.45 - $3.62

52 week range

$2.08 - $4.58

Profile about OSUR

CEO

Carrie Eglinton Manner

Employees

500

Headquarters

Bethlehem, PA

Exchange

Nasdaq Global Select

Shares outstanding

69047266

Issue type

Common Stock

OSUR industries and sectors

Healthcare

Medical Equipment & Supplies

News on OSUR

OraSure Technologies, Inc. (OSUR) Q3 2026 Earnings Call Transcript

OraSure Technologies, Inc. (OSUR) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

OraSure Technologies Q3 Earnings Call Highlights

OraSure Technologies NASDAQ: OSUR reported 14% year-over-year revenue growth in the third quarter of 2026, but pushed back its target for operating cash flow breakeven as the timing of several product opportunities shifted.

news source

MarketBeat • Nov 10, 2026

news preview

OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion

BETHLEHEM, Pa., Nov. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended September 30, 2026.

news source

GlobeNewsWire • Nov 9, 2026

news preview

OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care

Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation

news source

GlobeNewsWire • Nov 2, 2026

news preview

OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th

BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market closes. It will hold its quarterly conference call to discuss the results beginning at 5:00 p.m. Eastern Time on that day.

news source

GlobeNewsWire • Oct 26, 2026

news preview

OraSure Technologies Q2 Earnings Call Highlights

OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management products supported results.

news source

MarketBeat • Aug 6, 2026

news preview

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 6, 2026

news preview

OraSure Announces Second Quarter 2026 Financial Results

BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2026.

news source

GlobeNewsWire • Aug 5, 2026

news preview

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. It will hold its quarterly conference call to discuss the results beginning at 5 p.m. Eastern Time on that day.

news source

GlobeNewsWire • Jul 22, 2026

news preview

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic individuals and deceased patients. The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic individuals and deceased patients.

news source

GlobeNewsWire • Jul 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in OraSure Technologies Inc.

Open an M1 investment account to buy and sell OraSure Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in OSUR on M1